PT3500571T - Compostos de imidazo[1,2-a] piridina, composições que os compreendem, métodos para o uso no tratamento de doenças e seus métodos de preparação - Google Patents

Compostos de imidazo[1,2-a] piridina, composições que os compreendem, métodos para o uso no tratamento de doenças e seus métodos de preparação

Info

Publication number
PT3500571T
PT3500571T PT178217436T PT17821743T PT3500571T PT 3500571 T PT3500571 T PT 3500571T PT 178217436 T PT178217436 T PT 178217436T PT 17821743 T PT17821743 T PT 17821743T PT 3500571 T PT3500571 T PT 3500571T
Authority
PT
Portugal
Prior art keywords
methods
imidazo
compositions
preparing
treating diseases
Prior art date
Application number
PT178217436T
Other languages
English (en)
Original Assignee
Childrens Hospital Med Ct
The U S A As Represented By The Secretary Department Of Health And Human Services Office Of Tech Tra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Med Ct, The U S A As Represented By The Secretary Department Of Health And Human Services Office Of Tech Tra filed Critical Childrens Hospital Med Ct
Publication of PT3500571T publication Critical patent/PT3500571T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT178217436T 2016-08-17 2017-08-16 Compostos de imidazo[1,2-a] piridina, composições que os compreendem, métodos para o uso no tratamento de doenças e seus métodos de preparação PT3500571T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662375965P 2016-08-17 2016-08-17

Publications (1)

Publication Number Publication Date
PT3500571T true PT3500571T (pt) 2021-03-29

Family

ID=60812120

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178217436T PT3500571T (pt) 2016-08-17 2017-08-16 Compostos de imidazo[1,2-a] piridina, composições que os compreendem, métodos para o uso no tratamento de doenças e seus métodos de preparação

Country Status (9)

Country Link
US (1) US20220213094A1 (pt)
EP (2) EP3500571B1 (pt)
CA (1) CA3033755A1 (pt)
DK (1) DK3500571T3 (pt)
ES (1) ES2862314T3 (pt)
LT (1) LT3500571T (pt)
PL (1) PL3500571T3 (pt)
PT (1) PT3500571T (pt)
WO (1) WO2018038988A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11542261B2 (en) * 2016-08-17 2023-01-03 Children's Hospital Medical Center Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors
MX2021007426A (es) * 2018-12-20 2021-09-08 Incyte Corp Compuestos de imidazopiridazina e imidazopiridina como inhibidores de cinasa-2 de tipo receptor de activina.
JP2023538242A (ja) * 2020-07-31 2023-09-07 チルドレンズ ホスピタル メディカル センター 多環式ｉｒａｋ及びｆｌｔ３阻害化合物、並びにその使用
WO2022140647A1 (en) * 2020-12-23 2022-06-30 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof
WO2023116888A1 (zh) * 2021-12-23 2023-06-29 杭州多域生物技术有限公司 一种五元并六元化合物、制备方法、药物组合物和应用
WO2023239941A1 (en) * 2022-06-10 2023-12-14 Interline Therapeutics Inc. Imidazo(1,2-a)pyridine derivatives as ripk2 inhibitors
WO2023250431A2 (en) * 2022-06-22 2023-12-28 Children's Hospital Medical Center Multi-cyclic irak and flt3 inhibiting compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015076800A1 (en) * 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors

Also Published As

Publication number Publication date
EP3854796A1 (en) 2021-07-28
WO2018038988A2 (en) 2018-03-01
PL3500571T3 (pl) 2021-06-28
WO2018038988A3 (en) 2018-04-05
EP3500571B1 (en) 2020-12-30
EP3500571A2 (en) 2019-06-26
ES2862314T3 (es) 2021-10-07
DK3500571T3 (da) 2021-03-08
LT3500571T (lt) 2021-04-12
CA3033755A1 (en) 2018-03-01
US20220213094A1 (en) 2022-07-07

Similar Documents

Publication Publication Date Title
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
HK1258905A1 (zh) 作為ret激酶抑制劑的取代的吡唑並[1，5-a]吡啶化合物
ZA201802976B (en) N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
PL3500571T3 (pl) Związki imidazo[1,2-a]pirydynowe, kompozycje je zawierające, sposoby leczenia chorób z ich wykorzystaniem oraz sposoby ich wytwarzania
ME03427B (me) Pirazolo[1,5-a]pirimidin-5,7-diamin jedinjenja kao cdk inhibitori i njihova terapeutska primjena
ZA201808257B (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
ZA201900236B (en) Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof
HK1247203A1 (zh) 取代的咪唑並[1，2-α]吡啶-2-基胺化合物及其藥物組合物和使用方法
ZA201904236B (en) Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors
HK1225723A1 (zh) 取代的咪唑並[1，2-a]吡啶甲酰胺及其用途
IL290419B (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
IL265153A (en) 8-(azetidin-1-yl)-[4,2,1]triazolo[5,1-a]pyridinyl compounds, preparations and methods of use
HK1257427A1 (zh) 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法